Literature DB >> 18832322

Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins.

Zaed Z R Hamady1, Mark D Farrar1, Terence R Whitehead2, Keith T Holland1, J Peter A Lodge3, Simon R Carding1.   

Abstract

The use of genetically modified bacteria to deliver biologically active molecules directly to the gut has become an increasingly attractive area of investigation. The challenge of regulation of production of the therapeutic molecule and colonization of the bowel led us to investigate Bacteroides ovatus for the production of these molecules, due to its ability to colonize the colon and xylan utilization properties. Here we have identified the putative xylanase promoter. The 5' region of the corresponding mRNA was determined by 5'RACE analysis and the transcription initiation site was identified 216 bp upstream of the ATG start codon. The putative xylanase promoter was regulated by xylan in a dose- and time-dependent manner, and repressed by glucose. This promoter was subsequently used to direct the controlled expression of a gene encoding the human intestinal trefoil factor (TFF-3) after integration as a single copy into the chromosome of B. ovatus. The resulting strain produced biologically active TFF-3 in the presence of xylan. These findings identify the B. ovatus xylanase operon promoter and show that it can be utilized to direct xylan-inducible expression of heterologous eukaryotic genes in B. ovatus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832322     DOI: 10.1099/mic.0.2008/019109-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  10 in total

1.  Next-generation probiotics: the spectrum from probiotics to live biotherapeutics.

Authors:  Paul W O'Toole; Julian R Marchesi; Colin Hill
Journal:  Nat Microbiol       Date:  2017-04-25       Impact factor: 17.745

2.  Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota.

Authors:  Mark Mimee; Alex C Tucker; Christopher A Voigt; Timothy K Lu
Journal:  Cell Syst       Date:  2015-07-29       Impact factor: 10.304

Review 3.  If you eat it, or secrete it, they will grow: the expanding list of nutrients utilized by human gut bacteria.

Authors:  Robert W P Glowacki; Eric C Martens
Journal:  J Bacteriol       Date:  2020-11-09       Impact factor: 3.490

4.  Engineered Regulatory Systems Modulate Gene Expression of Human Commensals in the Gut.

Authors:  Bentley Lim; Michael Zimmermann; Natasha A Barry; Andrew L Goodman
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

5.  Novel xylan-controlled delivery of therapeutic proteins to inflamed colon by the human anaerobic commensal bacterium.

Authors:  Z Z R Hamady
Journal:  Ann R Coll Surg Engl       Date:  2013-05       Impact factor: 1.891

6.  Use of genetically modified bacteria for drug delivery in humans: Revisiting the safety aspect.

Authors:  Udo Wegmann; Ana Lucia Carvalho; Martin Stocks; Simon R Carding
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

7.  Bioengineering commensal bacteria-derived outer membrane vesicles for delivery of biologics to the gastrointestinal and respiratory tract.

Authors:  Ana L Carvalho; Sonia Fonseca; Ariadna Miquel-Clopés; Kathryn Cross; Khoon-S Kok; Udo Wegmann; Katherine Gil-Cordoso; Eleanor G Bentley; Sanaria H M Al Katy; Janine L Coombes; Anja Kipar; Regis Stentz; James P Stewart; Simon R Carding
Journal:  J Extracell Vesicles       Date:  2019-06-24

Review 8.  Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis.

Authors:  Xiaomin Su; Yunhuan Gao; Rongcun Yang
Journal:  Cells       Date:  2022-07-25       Impact factor: 7.666

Review 9.  Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease.

Authors:  Rebeca Martín; Sylvie Miquel; Jonathan Ulmer; Noura Kechaou; Philippe Langella; Luis G Bermúdez-Humarán
Journal:  Microb Cell Fact       Date:  2013-07-23       Impact factor: 5.328

10.  A Novel Tightly Regulated Gene Expression System for the Human Intestinal Symbiont Bacteroides thetaiotaomicron.

Authors:  Nikki Horn; Ana L Carvalho; Karin Overweg; Udo Wegmann; Simon R Carding; Régis Stentz
Journal:  Front Microbiol       Date:  2016-07-13       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.